Page last updated: 2024-11-01

nicardipine and Non-communicable Chronic Diseases

nicardipine has been researched along with Non-communicable Chronic Diseases in 1 studies

Nicardipine: A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents.
nicardipine : A racemate comprising equimolar amounts of (R)- and (S)-nicardipine. It is a calcium channel blocker which is used to treat hypertension.
2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine substituted by a methyl, {2-[benzyl(methyl)amino]ethoxy}carbonyl, 3-nitrophenyl, methoxycarbonyl and methyl groups at positions 2, 3, 4, 5 and 6, respectively.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Lee, S1
Ahn, YN1
Lee, J1
Kwon, S1
Kang, HY1

Trials

1 trial available for nicardipine and Non-communicable Chronic Diseases

ArticleYear
The effect on vital signs of concomitant administration of nicardipine and dexmedetomidine sedation after spinal anesthesia: A double-blind, randomized controlled trial.
    Medicine, 2023, Jul-07, Volume: 102, Issue:27

    Topics: Anesthesia, Spinal; Bradycardia; Dexmedetomidine; Double-Blind Method; Heart Rate; Humans; Hypnotics

2023